MVE 1 Introduction to Anatomy, Physiology, and Pharmaceutical Chemistry | Guess Papers of IGNOU 
MVE 2 Pharmacology and Toxicology | Guess Papers of IGNOU 
MVE 3 Pharmaceutics | Guess Papers of IGNOU 
MVE 5 Introduction to Management | Guess Papers of IGNOU 
MVE 6 Sales Management | Guess Papers of IGNOU 
MVE 4 Drugs Regulatory Affairs | Quick Readable...
Rs.149
| Product Name | Cart |
|---|---|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Category | : POST GRADUATE DIPLOMA PROGRAMMES |
| Sub Category | : Post Graduate Diploma in Pharmaceutical Sales Management (PGDPSM) |
| Products Code | : PGDPSM-MVE-6.35 |
| HSN Code | : 490110 |
| Language | : English, English |
| Author | : BMAP EDUSERVICES PVT LTD |
| Publisher | : BMAP EDUSERVICES PVT LTD |
| University | : IGNOU (Indira Gandhi National Open University) |
| Pages | : 50 |
| Weight | : 157gms |
| Dimensions | : 21.0 x 29.7 cm (A4 Size Pages) |
The MVE 4 Drugs Regulatory Affairs book is an essential resource for students pursuing the Post Graduate Diploma in Pharmaceutical Sales Management (PGDPSM). This comprehensive guide covers all the critical topics related to drug regulatory affairs, making it easier for students to understand complex regulations and procedures. It includes a range of important questions, derived from Guess Papers of IGNOU, that are likely to appear in exams. With 50-60 pages of focused content, this book ensures that students are well-prepared for their assessments.
Benefits of Using This Book:
DISCLAIMER
The IGNOU solved assignments and guess papers provided on this platform are for reference purposes only and should not be used to engage in educational dishonesty. These materials serve as learning and study tools and are not intended for submission as original work. Users are responsible for using these materials ethically and in accordance with their educational institution's guidelines. We do not assume liability for any misuse or consequences resulting from the use of these materials. By accessing and utilizing these resources, users agree to this disclaimer.
Chat with us
